StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
2670
This month
75
This week
23
This year
357
Today
2
Yesterday
8
Publishing Date
2024 - 01 - 04
11
2023 - 12 - 12
12
2023 - 12 - 06
13
2023 - 11 - 06
12
2023 - 10 - 31
12
2023 - 10 - 30
11
2023 - 10 - 23
10
2023 - 10 - 17
13
2023 - 10 - 16
11
2023 - 10 - 03
10
2023 - 09 - 28
12
2023 - 09 - 27
11
2023 - 09 - 26
16
2023 - 09 - 20
12
2023 - 09 - 18
12
2023 - 09 - 12
11
2023 - 09 - 11
13
2023 - 09 - 06
12
2023 - 08 - 15
10
2023 - 07 - 17
10
2023 - 07 - 11
12
2023 - 07 - 06
10
2023 - 06 - 28
11
2023 - 06 - 27
11
2023 - 06 - 21
10
2023 - 06 - 20
11
2023 - 06 - 08
10
2023 - 06 - 05
13
2023 - 05 - 31
14
2023 - 05 - 30
10
2023 - 05 - 25
11
2023 - 05 - 23
10
2023 - 05 - 11
13
2023 - 04 - 24
10
2023 - 02 - 22
10
2023 - 01 - 09
13
2023 - 01 - 05
11
2022 - 12 - 19
12
2022 - 12 - 15
12
2022 - 12 - 12
12
2022 - 12 - 08
11
2022 - 11 - 30
11
2022 - 11 - 03
11
2022 - 11 - 01
15
2022 - 10 - 31
12
2022 - 10 - 26
16
2022 - 10 - 24
10
2022 - 10 - 17
13
2022 - 10 - 13
10
2022 - 10 - 11
10
2022 - 09 - 27
11
2022 - 09 - 13
10
2022 - 09 - 08
11
2022 - 09 - 06
11
2022 - 08 - 23
13
2022 - 08 - 11
10
2022 - 08 - 01
11
2022 - 07 - 13
11
2022 - 07 - 12
12
2022 - 07 - 04
17
Sector
Commercial services
32
Communications
50
Consumer durables
12
Consumer non-durables
20
Consumer services
8
Distribution services
13
Electronic technology
57
Energy minerals
15
Finance
47
Finance and insurance
16
Health care and social assistance
9
Health services
40
Health technology
1654
Industrial services
11
Information
9
Manufacturing
240
Mining, quarrying, and oil and gas extraction
25
Miscellaneous
1
N/a
124
Non-energy minerals
34
Process industries
49
Producer manufacturing
59
Professional, scientific, and technical services
80
Real estate and rental and leasing
3
Retail trade
4
Technology services
95
Transportation
1
Transportation and warehousing
8
Utilities
10
Wholesale trade
14
Tags
Acquisition
7780
Agreement
3064
Application
2385
Approval
2336
Business
4468
Cancer
4278
Ceo
2615
Ces
2841
Collaboration
2372
Conference
23475
Corporation
5692
Covid
2539
Deadline
3250
Disease
2687
Distribution
2481
Drug
2775
Earnings
3673
Energy
7572
Europe
2400
Events
4815
Fda
3598
Financial
16187
Financial results
7597
Global
11779
Group
5192
Growth
12835
Health
5042
International
2444
Management
2810
Market
24519
Media
2246
Meeting
3625
N/a
282254
Nasdaq
3886
Offering
7173
Partnership
2841
People
2349
Pharma
2421
Pharmaceuticals
3032
Platform
2398
Positive
3033
Presentation
2956
Program
3934
Report
15997
Research
10646
Results
41658
Sales
2230
Services
3102
Solutions
2825
Spac
2406
Study
2670
System
2710
Technology
6612
Test
2258
Therapeutics
9579
Therapy
2864
Treatment
5299
Trial
6821
Update
5259
Year
7814
Entities
Abbvie inc.
8
Abvc biopharma inc
13
Akero therapeutics, inc.
11
Algernon pharmaceuticals inc.
11
Aligos therapeutics, inc.
10
Alnylam pharmaceuticals, inc.
12
Alterity therapeutics limited
9
Alvotech lux holdings s.a.s.
10
Amplitude healthcare acquisition corp
8
Annovis bio, inc.
9
Arrival
14
Arrowhead pharmaceuticals, inc.
13
Astellas pharma inc
14
Astrazeneca plc
8
Beigene, ltd.
9
Biogen inc.
14
Biomea fusion inc
17
Bridgebio pharma, inc.
13
Bristol-myers squibb company
9
Celldex therapeutics, inc.
10
Cisco systems, inc.
13
Cns pharmaceuticals, inc.
10
Cognition therapeutics inc
13
Dare bioscience, inc.
19
Eli lilly and company
74
Eloxx pharmaceuticals, inc.
10
Evotec se
9
Gilead sciences, inc.
11
Harmony biosciences holdings, inc.
10
Incyte corporation
37
Intellia therapeutics, inc.
10
Ionis pharmaceuticals, inc.
19
Johnson & johnson
67
Kamada ltd.
9
Kering
14
Kiora pharmaceuticals inc
9
Leap therapeutics, inc.
11
Ligand pharmaceuticals incorporated
13
Lithium corp
10
Masimo corporation
15
Medicenna therapeutics corp.
14
Mediwound ltd.
10
Medtronic plc
16
Microbot medical inc.
9
Morgan stanley
11
Natera, inc.
10
Neurocrine biosciences, inc.
11
Novartis ag
17
Orange
43
Palatin technologies, inc.
10
Pfizer, inc.
20
Sanofi
86
Seelos therapeutics, inc.
10
Sellas life sciences group, inc.
9
Silo pharma, inc.
14
Sorrento therapeutics, inc.
9
Sutro biopharma, inc.
14
Teva pharmaceutical industries ltd
20
Tonix pharmaceuticals holding corp.
24
Vaxcyte, inc.
11
Symbols
ABVC
13
AGNPF
11
AKRO
11
ALGS
10
ALNY
12
ALPMF
14
ALPMY
14
ALVO
10
ANVS
9
ARVL
14
ARWR
13
ATHE
9
BBIO
13
BGNE
9
BIIB
14
BMEA
17
BMY
9
CGTX
13
CLDX
10
CNSP
10
CSCO
13
DARE
19
ELOX
10
EVOTF
9
FNCTF
43
GILD
11
HRMY
10
INCY
37
IONS
19
JNJ
67
KMDA
9
KPRX
9
LGND
13
LLY
74
LPTX
11
LTUM
10
MASI
15
MBOT
9
MDNA
14
MDT
16
MDWD
10
MS
11
NBIX
11
NTLA
10
NTRA
10
NVS
17
NVSEF
15
PCVX
11
PFE
20
PPRUF
14
PPRUY
14
PTN
10
SEEL
10
SILO
14
SILOD
14
SNY
86
SNYNF
86
STRO
14
TEVJF
20
TNXP
24
Exchanges
Amex
60
Nasdaq
2297
Nyse
520
Crawled Date
2024 - 01 - 04
11
2023 - 12 - 12
12
2023 - 12 - 06
13
2023 - 11 - 06
12
2023 - 10 - 31
12
2023 - 10 - 30
11
2023 - 10 - 17
12
2023 - 10 - 16
12
2023 - 09 - 28
12
2023 - 09 - 27
11
2023 - 09 - 26
16
2023 - 09 - 20
12
2023 - 09 - 18
12
2023 - 09 - 12
11
2023 - 09 - 11
13
2023 - 09 - 06
12
2023 - 07 - 17
10
2023 - 07 - 11
12
2023 - 07 - 06
11
2023 - 06 - 28
11
2023 - 06 - 27
11
2023 - 06 - 21
10
2023 - 06 - 20
11
2023 - 06 - 08
10
2023 - 06 - 05
13
2023 - 05 - 31
14
2023 - 05 - 30
10
2023 - 05 - 25
11
2023 - 05 - 23
10
2023 - 05 - 11
12
2023 - 04 - 24
10
2023 - 04 - 17
10
2023 - 02 - 22
10
2023 - 01 - 09
13
2023 - 01 - 05
11
2023 - 01 - 04
10
2022 - 12 - 19
13
2022 - 12 - 15
12
2022 - 12 - 12
10
2022 - 12 - 08
10
2022 - 11 - 30
10
2022 - 11 - 03
11
2022 - 11 - 01
15
2022 - 10 - 31
11
2022 - 10 - 26
17
2022 - 10 - 24
11
2022 - 10 - 17
13
2022 - 10 - 13
10
2022 - 10 - 11
10
2022 - 09 - 28
11
2022 - 09 - 13
10
2022 - 09 - 08
10
2022 - 09 - 06
11
2022 - 08 - 23
13
2022 - 08 - 11
10
2022 - 08 - 01
11
2022 - 07 - 19
10
2022 - 07 - 13
11
2022 - 07 - 12
12
2022 - 07 - 04
17
Crawled Time
00:00
59
00:20
11
01:00
41
02:00
32
03:00
10
04:00
6
04:20
4
05:00
12
06:00
19
07:00
30
08:00
28
08:20
5
09:00
35
10:00
48
11:00
224
12:00
397
12:01
7
12:20
102
12:30
34
13:00
334
13:20
92
13:30
54
13:47
1
14:00
204
14:20
50
14:30
35
15:00
116
15:20
34
15:30
23
16:00
96
16:20
18
17:00
67
18:00
57
19:00
36
20:00
105
20:20
15
21:00
95
22:00
80
23:00
54
Source
alteritytherapeutics.com
7
anaptysbio.com
1
aslanpharma.com
1
brainsway.com
3
bridgebio.com
1
brightmindsbio.com
1
compasspathways.com
1
contravir.com
2
firstcobalt.com
1
immunitybio.com
3
investor.alkermes.com
1
investors.phiopharma.com
3
ionispharma.com
2
ir.akerotx.com
3
ir.ateapharma.com
1
ir.biolinerx.com
1
ir.kalvista.com
1
ir.pulmatrix.com
3
ir.vaccinex.com
3
ir.zynerba.com
1
jaguarhealth.gcs-web.com
2
neurosense.investorroom.com
7
nutriband.com
1
pagerduty.com
1
piedmontlithium.com
4
revivapharma.com
1
spacfeed.com
4
sunworksusa.com
1
www.algernonpharmaceuticals.com
1
www.americanlithiumcorp.com
1
www.anaptysbio.com
1
www.aquestive.com
1
www.atossatherapeutics.com
1
www.avricorehealth.com
1
www.bactechgreen.com
1
www.biospace.com
973
www.blackknightinc.com
1
www.cecorp.ca
2
www.celyad.com
1
www.clinuvel.com
3
www.concentrix.com
1
www.crinetics.com
3
www.cyanotech.com
1
www.enanta.com
1
www.fpxnickel.com
4
www.fsdpharma.com
1
www.globenewswire.com
976
www.hancockjaffe.com
2
www.hillintl.com
2
www.hutch-med.com
1
www.j2global.com
1
www.limoneira.com
2
www.lomiko.com
1
www.middleby.com
1
www.nantkwest.com
2
www.nextsourcematerials.com
1
www.predictmedix.com
2
www.prnewswire.com
611
www.sutrobio.com
2
www.thehackettgroup.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Study
save search
CENTURY LITHIUM PROVIDES UPDATE ON THE FEASIBILITY STUDY
Published:
2024-04-19
(Crawled : 12:00)
- prnewswire.com
CYDVF
|
News
|
$0.4786
-51.9%
43K
|
Non-Energy Minerals
|
Email alert
Add to watchlist
LTUM
|
News
|
$0.0364
33.16%
230K
|
Mining, Quarrying, and Oil and ...
|
Email alert
Add to watchlist
lithium
update
study
Todays' Top-5
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®
Published:
2024-04-19
(Crawled : 11:00)
- globenewswire.com
TLSA
|
News
|
$0.6698
4.66%
4.45%
600K
|
Health Technology
|
10.36%
|
O:
20.07%
H:
0.0%
C:
0.0%
today
anti-cd3
life
neurology
foralumab
sclerosis
sciences
results
study
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Published:
2024-04-18
(Crawled : 19:00)
- biospace.com/
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
0.75%
|
O:
0.75%
H:
0.0%
C:
0.0%
rinvoq
positive
cell
results
study
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Published:
2024-04-18
(Crawled : 13:00)
- globenewswire.com
ONCT
|
$8.97
4.3%
4.12%
4.5K
|
Health Technology
|
Email alert
Add to watchlist
onct-534
first
cancer
treatment
for
study
Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
Published:
2024-04-18
(Crawled : 12:00)
- globenewswire.com
IMMP
|
$2.25
2.27%
2.22%
90K
|
Health Technology
|
1.38%
|
O:
3.69%
H:
3.56%
C:
-2.22%
imp761
institute
research
study
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Published:
2024-04-18
(Crawled : 12:00)
- biospace.com/
BNTC
|
$6.89
1.03%
1.02%
250K
|
Health Technology
|
36.67%
|
O:
5.41%
H:
41.06%
C:
29.66%
bb-301
first
positive
biopharma
for
trial
opmd
study
Lantronix Case Study focuses on Reliable and Secure Support Provided to Financial Services Industry by its Out-of-Band Solutions
Published:
2024-04-18
(Crawled : 11:00)
- globenewswire.com
LTRX
|
$3.105
-1.43%
-1.45%
150K
|
Distribution Services
|
-0.32%
|
O:
-1.27%
H:
1.28%
C:
0.96%
services
solutions
financial
study
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
Published:
2024-04-18
(Crawled : 11:00)
- biospace.com/
BPTS
|
$0.29
-11.04%
-12.41%
180K
|
Manufacturing
|
1.05%
|
O:
1.05%
H:
0.0%
C:
0.0%
obesity
for
study
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
Published:
2024-04-17
(Crawled : 22:00)
- biospace.com/
EOLS
|
$11.49
-0.61%
-0.61%
350K
|
Health Technology
|
-1.49%
|
O:
-1.49%
H:
0.0%
C:
0.0%
jeuveau
publication
for
study
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
Published:
2024-04-17
(Crawled : 16:00)
- biospace.com/
HYPR
|
$0.855
5.56%
5.26%
57K
|
Manufacturing
|
-8.08%
|
O:
0.0%
H:
0.0%
C:
-8.08%
first
alzheimer’s
care
enroll
therapy
study
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
CLDX
|
$37.98
-1.43%
-1.45%
590K
|
Health Technology
|
0.23%
|
O:
0.23%
H:
0.0%
C:
0.0%
urticaria
study
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
Published:
2024-04-17
(Crawled : 12:00)
- biospace.com/
SAGE
|
$13.35
2.42%
2.36%
1.3M
|
Health Technology
|
-17.57%
|
O:
-15.02%
H:
3.55%
C:
-3.01%
sage-718
disease
treatment
topline
parkinson’s
therapeutics
results
study
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
Published:
2024-04-17
(Crawled : 11:00)
- globenewswire.com
ATAI
|
$1.85
-3.14%
-3.24%
940K
|
Manufacturing
|
4.87%
|
O:
4.87%
H:
0.0%
C:
0.0%
bpl-003
life
publication
sciences
study
Every Rand Lost to Fraud in South Africa Costs Firms R3.64 According to LexisNexis True Cost of Fraud Study
Published:
2024-04-17
(Crawled : 07:00)
- prnewswire.com
RELX
|
$41.07
-0.87%
0.0%
1.1M
|
Commercial Services
|
0.05%
|
O:
1.11%
H:
0.0%
C:
-1.05%
lexisnexis
africa
study
Every Dirham Lost to Fraud in UAE Costs Firms AED$4.19 According to LexisNexis True Cost of Fraud Study
Published:
2024-04-17
(Crawled : 05:00)
- prnewswire.com
RELX
|
$41.07
-0.87%
0.0%
1.1M
|
Commercial Services
|
0.05%
|
O:
1.11%
H:
0.0%
C:
-1.05%
lexisnexis
study
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
Published:
2024-04-16
(Crawled : 13:00)
- globenewswire.com
MYGN
F
|
$18.515
0.03%
0.03%
490K
|
Health Technology
|
-2.76%
|
O:
-2.61%
H:
0.0%
C:
0.0%
prequel
positive
for
study
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool
Published:
2024-04-16
(Crawled : 12:00)
- globenewswire.com
PALI
|
$4.735
-6.61%
-7.07%
140K
|
Manufacturing
|
60.78%
|
O:
113.15%
H:
10.29%
C:
-32.23%
pali-2108
study
Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid Tumors
Published:
2024-04-16
(Crawled : 12:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
|
2.28%
|
O:
2.93%
H:
3.8%
C:
-0.63%
ctx-8371
first
tumors
therapeutics
study
BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
Published:
2024-04-16
(Crawled : 12:00)
- globenewswire.com
BRTX
|
$1.39
-3.47%
-3.6%
160K
|
Professional, Scientific, and T...
|
0.77%
|
O:
9.23%
H:
15.49%
C:
-7.75%
brtx-100
fda
clearance
study
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
ITCI
1 d
|
$72.29
0.4%
0.4%
2.2M
|
Health Technology
|
13.12%
|
O:
14.75%
H:
12.75%
C:
6.04%
positive
topline
therapy
results
study
← Previous
1
2
3
4
5
6
7
8
9
…
133
134
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.